- $280.84m
- $296.44m
- $159.01m
- 49
- 42
- 66
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 107 | 112 | 127 | 139 | 159 |
Cost of Revenue | |||||
Gross Profit | 87.2 | 88.4 | 102 | 111 | 125 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 138 | 135 | 153 | 168 | 180 |
Operating Profit | -31.4 | -23.2 | -25.4 | -29.7 | -21.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -29.1 | -23.8 | -27 | -28.9 | -21.7 |
Net Income After Taxes | -29.1 | -23.8 | -27 | -28.9 | -21.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -29.1 | -23.8 | -27 | -28.9 | -21.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -29.1 | -23.8 | -27 | -28.9 | -21.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.743 | -0.595 | -0.655 | -0.688 | -0.506 |